Advertisement
Screener

PRECISION OPTICS CORPORATION, INC. (POCI) Deferred Revenue Recognized

2.8 / 5 stars · 68/120 Roast Me

PRECISION OPTICS CORPORATION, INC. Deferred Revenue Recognized

PRECISION OPTICS CORPORATION, INC. (POCI) reported Deferred Revenue Recognized of -$99.43 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Income Statement › Other Income

us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-05-13

  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was -$99.43K.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-12-31 was -$323.29K.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was -$922.07K.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was -$57.63K.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for fiscal 2025 was -$714.75K.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for fiscal 2024 was -$1.95M.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for fiscal 2020 was $587.45K, a 30.68% decline from fiscal 2019.
  • PRECISION OPTICS CORPORATION, INC. contract with customer, liability, revenue recognized for fiscal 2019 was $847.45K.
Period endContract with Customer, Liability, Revenue Recognized 3 monthContract with Customer, Liability, Revenue Recognized 3 month as first filedContract with Customer, Liability, Revenue Recognized 6 monthContract with Customer, Liability, Revenue Recognized 9 monthContract with Customer, Liability, Revenue Recognized 12 monthContract with Customer, Liability, Revenue Recognized 12 month as first filed
2026-03-31-$99.43K
10-Q · filed 2026-05-13
-$1.34M
10-Q · filed 2026-05-13
2025-12-31-$323.29K
10-Q · filed 2026-02-17
-$1.25M
10-Q · filed 2026-02-17
2025-09-30-$922.07K
10-Q · filed 2025-11-13
2025-06-30-$714.75K
10-K · filed 2025-09-29
2025-03-31-$57.63K
10-Q · filed 2026-05-13
-$645.37K
10-Q · filed 2026-05-13
2024-12-31-$50.32K
10-Q · filed 2026-02-17
-$587.75K
10-Q · filed 2026-02-17
2024-09-30-$537.42K
10-Q · filed 2025-11-13
2024-06-30-$1.95M
10-K · filed 2025-09-29
2024-03-31-$319.23K
10-Q · filed 2025-05-15
-$1.04M
10-Q · filed 2025-05-15
2023-12-31-$539.31K
10-Q · filed 2025-02-13
-$722.14K
10-Q · filed 2025-02-13
2023-09-30-$182.83K
10-Q · filed 2024-11-14
2023-03-31-$427.84K
10-Q · filed 2024-05-15
-$1.44M
10-Q · filed 2024-05-15
2022-12-31-$679.40K
10-Q · filed 2024-02-14
-$1.01M
10-Q · filed 2024-02-14
2022-09-30-$327.83K
10-Q · filed 2023-11-14
2022-03-31-$893.51K
10-Q · filed 2023-05-15
-$1.65M
10-Q · filed 2023-05-15
2021-12-31-$562.92K
10-Q · filed 2023-02-14
-$881.82K
10-Q · filed 2023-02-14
2021-09-30-$318.90K
10-Q · filed 2022-11-14
$318.90K
10-Q · filed 2021-11-15
2021-03-31$361.67K
10-Q · filed 2021-05-13
$798.56K
10-Q · filed 2021-05-13
2020-12-31$182.36K
10-Q · filed 2021-02-16
$436.88K
10-Q · filed 2021-02-16
2020-09-30$254.53K
10-Q · filed 2021-11-15
2020-06-30$587.45K
10-K · filed 2020-09-24
2020-03-31$119.86K
10-Q · filed 2021-05-13
$474.56K
10-Q · filed 2021-05-13
2019-12-31$222.26K
10-Q · filed 2021-02-16
$354.70K
10-Q · filed 2021-02-16
2019-09-30$216.67K
10-Q · filed 2020-11-12
2019-06-30$847.45K
10-K · filed 2020-09-24
$768.41K
10-K · filed 2019-09-26
2019-03-31$97.65K
10-Q · filed 2020-05-14
$680.60K
10-Q · filed 2020-05-14
2018-12-31$192.72K
10-Q · filed 2020-02-13
$674.16K
10-Q · filed 2020-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outset Medical, Inc. (OM)United States$0.059B-1.09
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
Streamex Corp. (STEX)United States$0.089B-0.19
IRIDEX CORP (IRIX)United States$0.011B
Nexalin Technology, Inc. (NXL)United States$0.094B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
Neuraxis, INC (NRXS)United States$0.097B
Nuwellis, Inc. (NUWE)United States$0.003B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B